Entred 3: A Study to Better Understand the Health Status and Quality of Life of People with Diabetes in Metropolitan France and the Overseas Departments

Santé publique France, in partnership with the French Health Insurance Fund, the Social Security Fund for the Self-Employed, the High Authority for Health, and the National Agency for Medicines and Health Products Safety, has launched the third edition of the national study on diabetes, Entred 3, to better understand the health status, quality of life, and healthcare utilization of people with diabetes, regardless of the type of diabetes.

Since March 2019, 9,000 people with diabetes living in mainland France and, more recently, 4,000 people with diabetes living in Réunion, Martinique, Guadeloupe, and French Guiana have been invited to complete a questionnaire on diabetes. Their doctors are also being asked to complete a supplementary medical questionnaire. This dual patient-physician approach is essential to addressing the challenges posed by diabetes.

We need as many people with diabetes and their doctors as possible to participate in order to ensure the quality of the data collected for this study and to apply it at the regional level. This information will help develop the prevention strategies essential to improving the health, medical care, and quality of life of people with diabetes.

For more information, visit http://santepubliquefrance.fr/entred3

Diabetes: What You Need to Know

Diabetes is a severe chronic disease that, as it progresses, can lead to serious complications affecting the heart, blood vessels, eyes, kidneys, and nerves. However, good management of the disease can significantly reduce these risks of complications.

In France, more than 3.3 million people are receiving pharmacological treatment for diabetes. While this figure has been rising steadily for several decades, a recent study presented at the Rencontres de Santé publique France in June 2019 and at the European Association for the Study of Diabetes congress in September 2019 showed, for the first time, that the number of people newly treated for type 2 diabetes decreased in France between 2012 and 2017.

These results, which confirm the international trend, offer a glimmer of hope and encourage continued prevention efforts to combat diabetes.